
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6164963
[patent_doc_number] => 20110195091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration'
[patent_app_type] => utility
[patent_app_number] => 13/059777
[patent_app_country] => US
[patent_app_date] => 2009-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6211
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195091.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059777 | Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration | Aug 12, 2009 | Abandoned |
Array
(
[id] => 6525503
[patent_doc_number] => 20100203498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/510150
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17263
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203498.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510150
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510150 | METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS | Jul 26, 2009 | Abandoned |
Array
(
[id] => 5484962
[patent_doc_number] => 20090274727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Recombinant RSV Virus Expression Systems And Vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/435024
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 34626
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435024
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435024 | Recombinant RSV Virus Expression Systems And Vaccines | May 3, 2009 | Abandoned |
Array
(
[id] => 6252157
[patent_doc_number] => 20100028377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Recombinant RSV Virus Expression Systems And Vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/434781
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 39850
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12434781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/434781 | Recombinant RSV Virus Expression Systems And Vaccines | May 3, 2009 | Abandoned |
Array
(
[id] => 5480928
[patent_doc_number] => 20090203885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Astrocyte Modulated Genes And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/422882
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17345
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203885.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422882
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422882 | Astrocyte Modulated Genes And Uses Thereof | Apr 12, 2009 | Abandoned |
Array
(
[id] => 5526776
[patent_doc_number] => 20090196853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'METHOD OF TREATING HEPATITIS VIRUS INFECTION WITH A MULTIPHASIC INTERFERON DELIVERY PROFILE'
[patent_app_type] => utility
[patent_app_number] => 12/420573
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15736
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196853.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420573 | METHOD OF TREATING HEPATITIS VIRUS INFECTION WITH A MULTIPHASIC INTERFERON DELIVERY PROFILE | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5929297
[patent_doc_number] => 20110039256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'DETECTION METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/921578
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13642
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039256.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921578 | DETECTION METHOD | Mar 26, 2009 | Abandoned |
Array
(
[id] => 6467783
[patent_doc_number] => 20100040645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'IN VIVO CTL ELICITATION BY HEAT SHOCK PROTEIN FUSION PROTEINS MAPS TO A DISCRETE DOMAIN AND IS CD4+ T CELL-INDEPENDENT'
[patent_app_type] => utility
[patent_app_number] => 12/400774
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13623
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400774
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400774 | IN VIVO CTL ELICITATION BY HEAT SHOCK PROTEIN FUSION PROTEINS MAPS TO A DISCRETE DOMAIN AND IS CD4+ T CELL-INDEPENDENT | Mar 8, 2009 | Abandoned |
Array
(
[id] => 5545895
[patent_doc_number] => 20090155772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Method for detecting nanbv associated seroconversion'
[patent_app_type] => utility
[patent_app_number] => 12/322370
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27087
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155772.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322370 | Method for detecting nanbv associated seroconversion | Jan 28, 2009 | Abandoned |
Array
(
[id] => 5473586
[patent_doc_number] => 20090246752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'APPARATUS AND METHOD FOR DETECTING MICROSCOPIC LIVING ORGANISMS USING BACTERIOPHAGE'
[patent_app_type] => utility
[patent_app_number] => 12/346656
[patent_app_country] => US
[patent_app_date] => 2008-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14640
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12346656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/346656 | APPARATUS AND METHOD FOR DETECTING MICROSCOPIC LIVING ORGANISMS USING BACTERIOPHAGE | Dec 29, 2008 | Abandoned |
Array
(
[id] => 5580553
[patent_doc_number] => 20090175899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/267231
[patent_app_country] => US
[patent_app_date] => 2008-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20471
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175899.pdf
[firstpage_image] =>[orig_patent_app_number] => 12267231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/267231 | RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES | Nov 6, 2008 | Abandoned |
Array
(
[id] => 33052
[patent_doc_number] => 07785875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same'
[patent_app_type] => utility
[patent_app_number] => 12/289766
[patent_app_country] => US
[patent_app_date] => 2008-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11469
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785875.pdf
[firstpage_image] =>[orig_patent_app_number] => 12289766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/289766 | Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same | Nov 2, 2008 | Issued |
Array
(
[id] => 5271524
[patent_doc_number] => 20090075300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/263139
[patent_app_country] => US
[patent_app_date] => 2008-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31161
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12263139
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/263139 | METHODS AND COMPOSITIONS FOR THE DETECTION OF CERVICAL DISEASE | Oct 30, 2008 | Abandoned |
Array
(
[id] => 5585428
[patent_doc_number] => 20090104630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent'
[patent_app_type] => utility
[patent_app_number] => 12/288180
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7723
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104630.pdf
[firstpage_image] =>[orig_patent_app_number] => 12288180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288180 | Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent | Oct 16, 2008 | Abandoned |
Array
(
[id] => 5422956
[patent_doc_number] => 20090149411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/253175
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13662
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149411.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253175
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253175 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF | Oct 15, 2008 | Abandoned |
Array
(
[id] => 6588786
[patent_doc_number] => 20100061995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Immunotherapy To Treat Or Prevent Viral Infection'
[patent_app_type] => utility
[patent_app_number] => 12/206157
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13374
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20100061995.pdf
[firstpage_image] =>[orig_patent_app_number] => 12206157
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/206157 | Immunotherapy To Treat Or Prevent Viral Infection | Sep 7, 2008 | Abandoned |
Array
(
[id] => 5507969
[patent_doc_number] => 20090081176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Cure for the human immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 12/231530
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 529
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081176.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231530 | Cure for the human immunodeficiency virus | Sep 2, 2008 | Abandoned |
Array
(
[id] => 5580543
[patent_doc_number] => 20090175889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'HIV VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/201014
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19620
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12201014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/201014 | HIV VACCINE | Aug 28, 2008 | Abandoned |
Array
(
[id] => 13977
[patent_doc_number] => 07807796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'ULBP antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/221490
[patent_app_country] => US
[patent_app_date] => 2008-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 28327
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12221490
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/221490 | ULBP antibodies | Aug 3, 2008 | Issued |
Array
(
[id] => 5585029
[patent_doc_number] => 20090104231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/174715
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13952
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104231.pdf
[firstpage_image] =>[orig_patent_app_number] => 12174715
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/174715 | VACCINE | Jul 16, 2008 | Abandoned |